Exact Mass: 442.1627596
Exact Mass Matches: 442.1627596
Found 151 metabolites which its exact mass value is equals to given mass value 442.1627596,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cortisol 21-sulfate
Cortisol 21-sulfate is also known as Cortisol-21-sulfuric acid or 4-Pregnen-11,17,21-triol-3,20-dione 21-sulfate. Cortisol 21-sulfate is considered to be practically insoluble (in water) and acidic. Cortisol 21-sulfate is a steroid conjugate lipid molecule D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Eltrombopag
B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
beta-D-Xylopyranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->2)-D-fucose
beta-D-Xylopyranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->2)-D-fucose is a constituent of desacylsaponins from the bark of Quillaja saponaria (soapbark tree). Constituent of desacylsaponins from the bark of Quillaja saponaria (soap-bark tree)
3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine
C16H31N2O10P (442.17162360000003)
3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine is an acylcarnitine. More specifically, it is an 3-[(2R)-2-hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
Eltrombopag
B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Antibiotic RP 1551-3
C25H27ClO5 (442.15469220000006)
(1S,3R,5S,6S,8S,9S,10R,13R)-1-acetoxy-3-bromo-6-hydroxy-8,13-epoxylabd-14-ene
C22H35BrO4 (442.17185700000005)
Dienestrol glucuronide|O1-[alpha,alpha-Di-((E)-aethyliden)-4-hydroxy-bibenzyl-4-yl]-beta-D-glucopyranuronsaeure|O1-[alpha,alpha-di-((E)-ethylidene)-4-hydroxy-bibenzyl-4-yl]-beta-D-glucopyranuronic acid
8-(4-Hydroxyphenylactyl),Me ester-6,8,15-Trihydroxy-2-oxo-1(10),3,11(13)-guaiatrien-12-oic acid|Methyl 2-oxo-6alpha,15-dihydroxy-8alpha-(p-hydroxyphenylacetoxy)-guaia-1(10),3,11-trien-5alphaH-12-oate
2-(3,4-Dimethoxyphenyl)-3,5-dimethoxy-7-(2-hydroxy-3-methyl-3-butenyloxy)-4H-1-benzopyran-4-one
BENZYL 2,3-DI-O-ACETYL-4,6-O-BENZYLIDEN-|A-D-GLUCOPYRANOSIDE
O-alpha-L-rhamnopyranosyl-(1-2)-O-alpha-L-rhamnopyranosyl-(1-5)-L-arabinose
C24H26O8_Spiro[furo[4,3,2-ij]pyrano[4,3:4,5]cyclohepta[1,2-f][2]benzopyran-7(9H),2-oxirane]-1,5,9,13(2H,3aH,11H)-tetrone, 5a,6,6a,13a,13b,13c-hexahydro-2,5a,11,11,13a-pentamethyl
Cys His Pro Ser
C17H26N6O6S (442.16344560000005)
Cys His Ser Pro
C17H26N6O6S (442.16344560000005)
Cys Pro His Ser
C17H26N6O6S (442.16344560000005)
Cys Pro Ser His
C17H26N6O6S (442.16344560000005)
Cys Ser His Pro
C17H26N6O6S (442.16344560000005)
Cys Ser Pro His
C17H26N6O6S (442.16344560000005)
Asp Asp Pro Pro
C18H26N4O9 (442.16997060000006)
Asp Pro Asp Pro
C18H26N4O9 (442.16997060000006)
Asp Pro Pro Asp
C18H26N4O9 (442.16997060000006)
His Cys Pro Ser
C17H26N6O6S (442.16344560000005)
His Cys Ser Pro
C17H26N6O6S (442.16344560000005)
His Pro Cys Ser
C17H26N6O6S (442.16344560000005)
His Pro Ser Cys
C17H26N6O6S (442.16344560000005)
His Ser Cys Pro
C17H26N6O6S (442.16344560000005)
His Ser Pro Cys
C17H26N6O6S (442.16344560000005)
Pro Cys His Ser
C17H26N6O6S (442.16344560000005)
Pro Cys Ser His
C17H26N6O6S (442.16344560000005)
Pro Asp Asp Pro
C18H26N4O9 (442.16997060000006)
Pro Asp Pro Asp
C18H26N4O9 (442.16997060000006)
Pro His Cys Ser
C17H26N6O6S (442.16344560000005)
Pro His Ser Cys
C17H26N6O6S (442.16344560000005)
Pro Pro Asp Asp
C18H26N4O9 (442.16997060000006)
Pro Ser Cys His
C17H26N6O6S (442.16344560000005)
Pro Ser His Cys
C17H26N6O6S (442.16344560000005)
Ser Cys His Pro
C17H26N6O6S (442.16344560000005)
Ser Cys Pro His
C17H26N6O6S (442.16344560000005)
Ser His Cys Pro
C17H26N6O6S (442.16344560000005)
Ser His Pro Cys
C17H26N6O6S (442.16344560000005)
Ser Pro Cys His
C17H26N6O6S (442.16344560000005)
Ser Pro His Cys
C17H26N6O6S (442.16344560000005)
Ser Ser Ser Tyr
C18H26N4O9 (442.16997060000006)
Ser Ser Tyr Ser
C18H26N4O9 (442.16997060000006)
Ser Tyr Ser Ser
C18H26N4O9 (442.16997060000006)
Tyr Ser Ser Ser
C18H26N4O9 (442.16997060000006)
b-D-Xylopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->2)-D-fucose
ST 21:3;O5;S
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
dibutyl [(dipropoxyphosphinothioyl)thio]succinate
C18H35O6PS2 (442.16125800000003)
acetyl 4-[6-(4-acetyloxycarbonylphenoxy)hexoxy]benzoate
Benzo[1,2-b:4,5-b]dithiophene, 2,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)
C22H28B2O4S2 (442.16150280000005)
Acepromazine maleate
C23H26N2O5S (442.15623460000006)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
(-)-1,1-bis((2s,4s)-2,4-diethylphosphotano)ferrocene
C24H36FeP2 (442.16415059999997)
TRIS(2,6-DIMETHOXYPHENYL)PHOSPHINE
C24H27O6P (442.15451720000004)
(s)-1-[(1r)-2-(diphenylphosphino)ferrocenyl]ethyldi-tert-butylphosphine
C24H36FeP2 (442.16415059999997)
BRL 15572 hydrochloride
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists
(1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)[6-(Methylsulfonyl)-4-Methoxy-2-Methyl-1,1-Biphenyl-3-Yl]methanone
C23H26N2O5S (442.15623460000006)
3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine
C16H31N2O10P (442.17162360000003)
N-(3,4-dimethylphenyl)-2-[N-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-methoxyanilino]acetamide
C22H26N4O4S (442.16746760000007)
[4-methoxy-3-(4-morpholinylsulfonyl)phenyl]-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methanone
C23H26N2O5S (442.15623460000006)
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl hydrogen sulfate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
cortisol 21-sulfate
A steroid sulfate obtained by the formal condensation of hydroxy group at position 21 of cortisol with sulfuric acid. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
2-({4,5-dihydroxy-6-methyl-2-[(3,4,5-trihydroxyoxolan-2-yl)methoxy]oxan-3-yl}oxy)-6-methyloxane-3,4,5-triol
4-{4-[4-(acetyloxy)-3-methoxyphenyl]-hexahydrofuro[3,4-c]furan-1-yl}-2-methoxyphenyl acetate
18,19-dimethoxy-13,14-dimethyl-20-oxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4,9,11(21),16,18-pentaen-12-yl acetate
(2s,3r,4r,5r,6s)-2-{[(2r,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-2-{[(2s,3r,4r,5s)-3,4,5-trihydroxyoxolan-2-yl]methoxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol
2-[(5-heptyl-7-hydroxy-4-oxochromen-2-yl)methyl]-3,4,6-trihydroxybenzoic acid
acetoxyl oxokadsurane
{"Ingredient_id": "HBIN014435","Ingredient_name": "acetoxyl oxokadsurane","Alias": "NA","Ingredient_formula": "C24H26O8","Ingredient_Smile": "CC1CC2=CC(=C(C(=O)C23COC4=C3C(=CC5=C4OCO5)C(C1C)OC(=O)C)OC)OC","Ingredient_weight": "442.5 g/mol","OB_score": "28.59565179","CAS_id": "NA","SymMap_id": "SMIT11596","TCMID_id": "NA","TCMSP_id": "MOL010567","TCM_ID_id": "NA","PubChem_id": "49770118","DrugBank_id": "NA"}
1-{3-[(6-acetyl-5,7-dihydroxy-2,2-dimethylchromen-8-yl)methyl]-2,6-dihydroxy-4-methoxy-5-methylphenyl}ethanone
{5-[3-(acetyloxy)prop-1-en-1-yl]-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-2,3-dihydro-1-benzofuran-3-yl}methyl acetate
(2e)-3-[(2s,3r)-3-[(acetyloxy)methyl]-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-en-1-yl acetate
3-(acetyloxy)-6-(2h-1,3-benzodioxol-5-yl)-5-methoxy-7-methyl-4-oxo-1-(prop-2-en-1-yl)bicyclo[3.2.1]oct-2-en-8-yl acetate
(2s)-2,4,9-trihydroxy-5,6-dimethoxy-7-methyl-8-(3-methylbut-2-en-1-yl)-2-(2-oxopropyl)phenalene-1,3-dione
(1'r,2r,2's,12'r,14'r,17'r,19'r,21's)-2',6',6',14',19'-pentamethyl-7',16',18'-trioxaspiro[oxirane-2,11'-pentacyclo[12.6.1.0²,¹².0⁵,¹⁰.0¹⁷,²¹]henicosane]-4',9'-diene-3',8',15',20'-tetrone
2,2-dimethyl-3-[(2-methylbut-2-enoyl)oxy]-8-oxo-3h,4h-pyrano[3,2-g]chromen-4-yl 2,3-dimethyloxirane-2-carboxylate
2,4,9-trihydroxy-5,6-dimethoxy-7-methyl-8-(3-methylbut-2-en-1-yl)-2-(2-oxopropyl)phenalene-1,3-dione
2-(4-hydroxy-3-methoxyphenyl)-3,5,8-trimethoxy-7-[(3-methylbut-2-en-1-yl)oxy]chromen-4-one
methyl 4-hydroxy-2-{[4-hydroxy-3-(3-hydroxy-3-methylbutyl)phenyl]methyl}-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate
(2s,3r)-3,4,8-trihydroxy-2-(2-hydroxypropan-2-yl)-7-methoxy-6-(3-methylbut-2-en-1-yl)-2h,3h-furo[3,2-b]xanthen-5-one
4-[(1s,3ar,4s,6ar)-4-[4-(acetyloxy)-3-methoxyphenyl]-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenyl acetate
(6as,9r,9as)-9-[(2e)-but-2-enoyl]-5-chloro-3-[(1e,3e,5r)-3,5-dimethylhepta-1,3-dien-1-yl]-6a-methyl-9h,9ah-furo[2,3-h]isochromene-6,8-dione
C25H27ClO5 (442.15469220000006)
1-[(3s)-6-hydroxy-8-methoxy-3,5-dimethyl-3,4-dihydro-1h-2-benzopyran-1-yl]-4h-pyrrolizino[1,2-b]quinoline-9,10-dione
(6as,9s,9as)-9-[(2e)-but-2-enoyl]-5-chloro-3-[(1e,3e)-3,5-dimethylhepta-1,3-dien-1-yl]-6a-methyl-9h,9ah-furo[2,3-h]isochromene-6,8-dione
C25H27ClO5 (442.15469220000006)
(3r,4as,6s,6as,8r,10s,10ar,10bs)-8-bromo-3-ethenyl-6-hydroxy-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-10-yl acetate
C22H35BrO4 (442.17185700000005)
(3r,4r)-2,2-dimethyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}-8-oxo-3h,4h-pyrano[3,2-g]chromen-4-yl (2s,3s)-2,3-dimethyloxirane-2-carboxylate
2-acetyl-4-[(8-acetyl-5,7-dihydroxy-2,2-dimethylchromen-6-yl)methyl]-3,5-dihydroxy-6,6-dimethylcyclohexa-2,4-dien-1-one
2',6',6',14',19'-pentamethyl-7',16',18'-trioxaspiro[oxirane-2,11'-pentacyclo[12.6.1.0²,¹².0⁵,¹⁰.0¹⁷,²¹]henicosane]-4',9'-diene-3',8',15',20'-tetrone
19-hydroxy-7,7,13,18,21-pentamethyl-6,11,14,16-tetraoxaspiro[hexacyclo[16.3.1.0³,⁸.0¹⁰,²¹.0¹²,²⁰.0¹⁵,¹⁹]docosane-2,2'-oxirane]-3,8,12(20)-triene-5,17-dione
(3s,6r)-3-({4-[(2s)-2,3-dihydroxy-3-methylbutoxy]phenyl}methyl)-1,4-dimethyl-3,6-bis(methylsulfanyl)piperazine-2,5-dione
methyl 2-[(3as,4r,5s,6s)-4-hydroxy-3-(hydroxymethyl)-6-{[2-(4-hydroxyphenyl)acetyl]oxy}-8-methyl-1-oxo-4,5,6,7-tetrahydro-3ah-azulen-5-yl]prop-2-enoate
1-(6-hydroxy-8-methoxy-3,5-dimethyl-3,4-dihydro-1h-2-benzopyran-1-yl)-4h-pyrrolizino[1,2-b]quinoline-9,10-dione
(1s,12s,13s,14s)-18,19-dimethoxy-13,14-dimethyl-20-oxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4,9,11(21),16,18-pentaen-12-yl acetate
(1r,2r,10s,13r,15r,18r,19r,21s)-19-hydroxy-7,7,13,18,21-pentamethyl-6,11,14,16-tetraoxaspiro[hexacyclo[16.3.1.0³,⁸.0¹⁰,²¹.0¹²,²⁰.0¹⁵,¹⁹]docosane-2,2'-oxirane]-3,8,12(20)-triene-5,17-dione
(1s,12r,13r,14r)-18,19-dimethoxy-13,14-dimethyl-20-oxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4,9,11(21),16,18-pentaen-12-yl acetate
1-[3,5-dimethoxy-4-({5-methoxy-[1,1'-biphenyl]-4-yl}oxy)phenyl]propane-1,2,3-triol
methyl 2-[4-hydroxy-3-(hydroxymethyl)-6-{[2-(4-hydroxyphenyl)acetyl]oxy}-8-methyl-1-oxo-4,5,6,7-tetrahydro-3ah-azulen-5-yl]prop-2-enoate
(1's,2s,2'r,12's,14's,17's,19'r,21'r)-2',6',6',14',19'-pentamethyl-7',16',18'-trioxaspiro[oxirane-2,11'-pentacyclo[12.6.1.0²,¹².0⁵,¹⁰.0¹⁷,²¹]henicosane]-4',9'-diene-3',8',15',20'-tetrone
3,4,8-trihydroxy-2-(2-hydroxypropan-2-yl)-7-methoxy-6-(3-methylbut-2-en-1-yl)-2h,3h-furo[3,2-b]xanthen-5-one
9-(but-2-enoyl)-5-chloro-3-(3,5-dimethylhepta-1,3-dien-1-yl)-6a-methyl-9h,9ah-furo[2,3-h]isochromene-6,8-dione
C25H27ClO5 (442.15469220000006)